Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · IEX Real-Time Price · USD
106.27
+0.31 (0.29%)
At close: Jul 2, 2024, 4:00 PM
106.81
+0.54 (0.51%)
After-hours: Jul 2, 2024, 7:34 PM EDT
Zimmer Biomet Holdings Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for ZBH stock have an average target of 132.19, with a low estimate of 115 and a high estimate of 155. The average target predicts an increase of 24.39% from the current stock price of 106.27.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ZBH stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Buy | 6 | 6 | 5 | 5 | 5 | 4 |
| Hold | 10 | 10 | 9 | 9 | 9 | 10 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 17 | 18 | 18 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $130 → $115 | Hold | Maintains | $130 → $115 | +8.21% | Jul 2, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $140 → $115 | Buy → Hold | Downgrades | $140 → $115 | +8.21% | Jul 1, 2024 |
| Barclays | Barclays | Sell Maintains $130 → $125 | Sell | Maintains | $130 → $125 | +17.62% | May 31, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $129 | Hold | Initiates | $129 | +21.39% | May 30, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 30, 2024 |
Financial Forecast
Revenue This Year
7.83B
from 7.39B
Increased by 5.89%
Revenue Next Year
8.20B
from 7.83B
Increased by 4.70%
EPS This Year
8.17
from 4.88
Increased by 67.42%
EPS Next Year
8.77
from 8.17
Increased by 7.39%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.2B | 8.6B | 9.1B | 9.5B | 9.9B |
| Avg | 7.8B | 8.2B | 8.6B | 8.9B | 9.3B |
| Low | 7.5B | 7.8B | 8.1B | 8.4B | 8.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.5% | 10.2% | 10.9% | 10.8% | 10.8% |
| Avg | 5.9% | 4.7% | 4.4% | 4.6% | 3.6% |
| Low | 1.6% | -0.2% | -1.1% | -2.0% | -3.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.58 | 9.31 | 10.21 | 10.61 | 11.37 |
| Avg | 8.17 | 8.77 | 9.43 | 10.00 | 9.52 |
| Low | 7.72 | 8.27 | 8.71 | 9.30 | 6.79 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 75.8% | 14.0% | 16.3% | 12.5% | 13.8% |
| Avg | 67.4% | 7.4% | 7.5% | 6.0% | -4.8% |
| Low | 58.2% | 1.2% | -0.7% | -1.4% | -32.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.